What are the recommended acute and preventive treatment options for menstrual migraine?

Menstrual Migraine Treatment

For acute treatment of menstrual migraine, start with combination therapy of a triptan plus an NSAID, as this provides superior efficacy compared to monotherapy; for prevention, use short-term prophylaxis with frovatriptan starting 2 days before expected menstruation and continuing for 5-6 days.

Acute Treatment Algorithm

First-Line: Combination Therapy

Start treatment as soon as the migraine begins with a triptan combined with an NSAID (or acetaminophen if NSAIDs are contraindicated) 1. This combination approach is more effective than either medication alone for menstrual migraine attacks, which are typically more severe and longer-lasting than non-menstrual migraines 2.

Specific triptan selection for menstrual migraine:

• Rizatriptan has the strongest evidence for acute menstrual migraine treatment, with 2-hour pain freedom rates of 33-73% and sustained pain relief of 63% between 2-24 hours 3
• Sumatriptan and lasmiditan demonstrated superior pain relief at both 2 hours (OR: 4.62) and 24 hours (OR: 4.81) 2
• Choose specific agents based on route of administration preference and cost 1

Second-Line Options

If combination therapy fails or is not tolerated:

• CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant for moderate to severe attacks 1
• Lasmiditan if all other treatments have failed 1
• Non-oral triptan plus antiemetic if severe nausea/vomiting is present 1

Critical Contraindications

Do not use opioids or butalbital for menstrual migraine treatment 1.

Preventive Treatment Algorithm

Determine Prevention Strategy

Consider prevention if:

• Severe debilitating headaches despite adequate acute treatment
• Unable to tolerate or have contraindications to acute treatment
• Using acute treatment more frequently than recommended 4

Short-Term Prevention (Perimenstrual Prophylaxis)

For pure menstrual migraine (attacks only during menstruation):

First-line: Frovatriptan

• Start 2 days before expected migraine onset
• Continue for 5-6 days total
• Frovatriptan is the mainstay of short-term prevention and most effective triptan for preventing headache recurrence 2, 5, 3
• Dosing: typically twice daily during the perimenstrual window

Alternative short-term options:

• Zolmitriptan three times daily 3
• Naratriptan twice daily 3
• Naproxen sodium 3
• Magnesium 3

Daily Prevention (For Menstrually-Related Migraine)

When attacks occur both during menstruation AND at other times in the cycle:

Follow standard migraine prevention guidelines 4:

• Beta-blockers (propranolol, metoprolol)
• Anticonvulsants (topiramate, valproate)
• Antidepressants (amitriptyline, venlafaxine)
• CGRP monoclonal antibodies (erenumab, galcanezumab) - these show superior efficacy in reducing monthly headache days compared to triptans 2

Cost considerations: Prioritize less expensive options first, as recommended treatments have similar net benefits 4.

Hormonal Considerations

Contraceptive Options

For appropriate candidates without contraindications:

• Continuous combined hormonal contraceptives (CHCs) with no placebo pills or only 2 placebo days to avoid estrogen withdrawal 6
• Extended-cycle regimens may be suitable for women requiring hormonal replacement 7

Critical Warning

Absolute contraindication: Do NOT use CHCs in women with menstrual migraine WITH aura, especially with additional risk factors like smoking - this represents an unacceptable health risk per U.S. Medical Eligibility Criteria 6.

Drug Interactions

Be aware that antiepileptic medications used for prevention can affect oral contraceptive efficacy:

• Topiramate has least effect at doses <200 mg/day 3
• Lamotrigine significantly decreases oral contraceptive levels 3

Medication Overuse Headache Prevention

Monitor frequency of acute medication use:

• NSAIDs: ≥15 days per month triggers medication overuse headache
• Triptans: ≥10 days per month triggers medication overuse headache 1

Special Populations

For women of childbearing potential, pregnant, or breastfeeding: Discuss adverse effects of all pharmacologic treatments during pregnancy and lactation before initiating therapy 1.

Treatment Initiation and Monitoring

• Start preventive medications at low doses and titrate gradually 4
• Allow 2-3 months for adequate trial before switching 4
• Use a headache diary to track efficacy and identify analgesic overuse 4
• Emphasize adherence as improvement occurs gradually over weeks 4

Lifestyle Modifications

Address modifiable triggers before or alongside pharmacologic treatment:

• Maintain hydration and regular meals
• Ensure consistent, adequate sleep
• Engage in regular moderate-to-intense aerobic exercise
• Practice stress management techniques
• Pursue weight loss if overweight/obese 1